GlassScriptPhysician profile
David Tigtig
NPI 1114379831
$12,491.61
in general payments reported to CMS, 2019-2025
35 companies · $2,922 in 2025
The $2,922 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,988 · 2022: $2,134 · 2023: $3,405 · 2024: $2,042 · 2025: $2,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,369.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,319.98 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,873.71 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,722.74 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $986.70 | 2022-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $821.72 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $757.09 | 2021-2025 | Watchman Flx, Watchman Access System |
| Merck Sharp & Dohme LLC | $659.95 | 2022-2025 | Verquvo, Capvaxive |
| Esperion Therapeutics, INC. | $592.90 | 2021-2025 | Nexletol |
| Bard Peripheral Vascular, INC. | $408.94 | 2023-2025 | Rotarexs 6 F X 135 Cm, Venclose Maven Catheter, Venovo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $311.00 | 2021-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.97 | 2021-2024 | Jardiance |
| Medtronic, INC. | $208.71 | 2021-2025 | Hawkone, Venaseal |
| Astrazeneca Pharmaceuticals LP | $207.66 | 2021-2025 | Farxiga, Wainua |
| Scpharmaceuticals INC. | $199.33 | 2025 | |
| Sanofi-Aventis U.S. LLC | $188.88 | 2021-2023 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $155.88 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Actelion Pharmaceuticals US, INC. | $133.01 | 2025 | Uptravi, Opsumit |
| Impulse Dynamics (USA) INC. | $97.67 | 2021-2023 | Optimizer |
| Tactile Systems Technology INC | $74.64 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Amarin Pharma, INC. | $60.70 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $58.25 | 2025 | Amvuttra |
| Pfizer INC. | $53.18 | 2022-2024 | |
| Chiesi USA, INC. | $41.96 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $38.23 | 2021-2022 | |
| Inspire Medical Systems, INC. | $36.26 | 2025 | Inspire |
| Cvrx, INC. | $29.70 | 2023 | Barostim Neo System |
| Azurity Pharmaceuticals, INC. | $24.13 | 2025 | Edarbyclor |
| Kestra Medical Technology Services, INC. | $21.74 | 2024 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $18.78 | 2023 | Inpefa |
| Cashflow Solutions, LLC | $16.29 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Inari Medical, INC. | $16.23 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Angiodynamics, INC. | $16.00 | 2021 | |
| Cleerly, INC. | $15.99 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Resmed Corp | $14.53 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Tigtig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.